| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 6,865,600 | 6,913,900 | | Cost of Revenue | 5,741,900 | 5,729,300 | | | Gross Profit | 1,123,700 | 1,184,600 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 1,225,400 | 970,200 | | Non Recurring | 149,200 | (1,668,900) | | Others | 75,700 |
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (326,600) | 1,883,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 30,800 | 17,800 | | Earnings Before Interest And Taxes | (269,000) | 1,943,200 | | Interest Expense | 180,200 | 199,100 | | Income Before Tax | (449,200) | 1,744,100 | | Income Tax Expense | 18,700 | 331,800 | | Minority Interest | 3,100 | 4,200 | | | | Net Income From Continuing Ops | (467,900) | 1,412,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (467,900) | 1,412,300 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($467,900) | $1,412,300 |
|
0.01% Nasdaq 0.00%
Income Statement
